CystoSure® Leadership
Ron Adams
Co-Founder & President
Mr. Adams has led Emmy Medical from its inception in July 2013 through its development, FDA Clearance and commercial launch in May 2015.
He has spent 23 years commercializing innovative medical devices and procedures and has a track record of building and directing world-class teams and organizations.
He served as Co-Founder and Chief Technology Officer at Interlace Medical, which was acquired by Hologic in 2011 for $265MM.
Previously he has held senior R&D leadership roles at Boston Scientific, Smith & Nephew and Ethicon Endosurgery. Mr. Adams is a listed inventor on over 60 US and PCT patents.
He has spent 23 years commercializing innovative medical devices and procedures and has a track record of building and directing world-class teams and organizations.
He served as Co-Founder and Chief Technology Officer at Interlace Medical, which was acquired by Hologic in 2011 for $265MM.
Previously he has held senior R&D leadership roles at Boston Scientific, Smith & Nephew and Ethicon Endosurgery. Mr. Adams is a listed inventor on over 60 US and PCT patents.
The impact CystoSure® brings to the clinical community is profound. It is tremendous to offer a technology that makes the lives of surgeons and staff easier, the care for patients better, simultaneously supporting the goal of improving healthcare efficiencies and economics in general.
Jim Greenberg, MD
Co-Founder & Inventor
Dr. Greenberg invented CystoSure® while exploring methods to improve cystoscopic access to patients in Rwanda.
He is a practicing Ob/Gyn as well as the Chief of Gynecology at Brigham & Women’s Faulkner Hospital and a Vice Chairman of Obstetrics & Gynecology at Brigham and Women’s Hospital.
He was the lead medical consultant at Interlace Medical which was acquired by Hologic in 2011.
In addition, he has served as a medical device consultant for multiple companies including Ethicon Endosurgery, Hologic, Smith & Nephew, Channel MedSystems and others. He routinely reviews and publishes new product reviews for various trade journals.
He is a practicing Ob/Gyn as well as the Chief of Gynecology at Brigham & Women’s Faulkner Hospital and a Vice Chairman of Obstetrics & Gynecology at Brigham and Women’s Hospital.
He was the lead medical consultant at Interlace Medical which was acquired by Hologic in 2011.
In addition, he has served as a medical device consultant for multiple companies including Ethicon Endosurgery, Hologic, Smith & Nephew, Channel MedSystems and others. He routinely reviews and publishes new product reviews for various trade journals.
Nothing has changed for female cystoscopy in the last 100 years so I created CystoSure® to offer a simpler and easier means for doctors to scope patients. While I may be the inventor, incorporating CystoSure® and routine cystoscopy for my patients, has provided me with peace of mind at the end of my cases.
Neeraj Kohli, MD, MBA
Co-Founder & Chief Medical Officer
Dr. Kohli is a nationally and internationally recognized leader in the field of Urogynecology and Reconstructive Pelvic Surgery.
He has authored more than 100 scientific articles, book chapters, research abstracts, clinical presentations, and multimedia educational tools.
He was previously the Co-Director of the Division of Urogynecology and Reconstructive Pelvic Surgery at Mount Auburn Hospital, Director of the Fellowship in Urogynecology, and Director of Urogynecology at Tufts New England Medical Center in Boston.
He founded the Division of Urogynecology at Brigham and Women's Hospital and was Division Chief from 2003 till 2010 when he left to start the Boston Urogyn.
He has authored more than 100 scientific articles, book chapters, research abstracts, clinical presentations, and multimedia educational tools.
He was previously the Co-Director of the Division of Urogynecology and Reconstructive Pelvic Surgery at Mount Auburn Hospital, Director of the Fellowship in Urogynecology, and Director of Urogynecology at Tufts New England Medical Center in Boston.
He founded the Division of Urogynecology at Brigham and Women's Hospital and was Division Chief from 2003 till 2010 when he left to start the Boston Urogyn.
CystoSure is a game changer. In my clinical practice, I am able to provide comprehensive bladder evaluation in a single visit, eliminating the need for my patients to make multiple visits. This provides them with immediate feedback and peace of mind about their underlying concerns, and enables us to see more patients and provide greater care.